Retinitis pigmentosa denotes a heterogeneous group of rare genetic diseases in which both rods and cones eye are damaged. It is a disease of poor prognosis. We describe the case of a 22 years old woman successfully treated with intravitreal implant of dexamentasone (OZURDEX®, Allergan, USA) for the treatment of macular edema due to retinitis pigmentosa.
Retinitis pigmentosa; Macular edema; Macular edema; Injections; Drug implants; Dexamethasone; Visual acuity; Humans; Female; Adult; Case report
